{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:59:18Z","timestamp":1762865958188},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,15]]},"DOI":"10.1093\/cid\/cir924","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T16:24:19Z","timestamp":1332174259000},"page":"S233-S238","source":"Crossref","is-referenced-by-count":49,"title":["Unmet Needs and Prospects for Oritavancin in the Management of Vancomycin-Resistant Enterococcal Infections"],"prefix":"10.1093","volume":"54","author":[{"given":"Cesar A.","family":"Arias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,4,15]]},"reference":[{"key":"key\n\t\t\t\t20171014000644_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.4.5-6.521","article-title":"A case of acute endocarditis caused by Micrococcus zymogenes (nov. spec.), with a description of the microorganism","volume":"4","author":"MacCallum","year":"1899","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171014000644_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1345\/aph.1K548","article-title":"Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?","volume":"42","author":"Schwartz","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171014000644_bib3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20171014000644_bib4","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.49.4.1664-1665.2005","article-title":"Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy","volume":"49","author":"Lewis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib5","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014000644_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/clinids\/20.1.16","article-title":"Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem","volume":"20","author":"Fernandez-Guerrero","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014000644_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1469-0691.2007.01746.x","article-title":"Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk","volume":"13","author":"Giannitsioti","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171014000644_bib8","first-page":"821","article-title":"Studies on antibiotic synergism against enterococci. I. Bacteriologic studies","volume":"77","author":"Moellering","year":"1971","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20171014000644_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9343(51)90273-2","article-title":"Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin","volume":"10","author":"Robbins","year":"1951","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171014000644_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JB.105.3.873-879.1971","article-title":"Mechanism of resistance to antibiotic synergism in enterococci","volume":"105","author":"Zimmermann","year":"1971","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171014000644_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/infdis\/147.4.751","article-title":"High-level resistance to gentamicin in clinical isolates of enterococci","volume":"147","author":"Mederski-Samoraj","year":"1983","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000644_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"146","author":"Gavalda","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014000644_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/mdr.1996.2.209","article-title":"Intrinsic penicillin resistance in enterococci","volume":"2","author":"Fontana","year":"1996","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20171014000644_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2217\/fmb.09.82","article-title":"Transition of Enterococcus faecium from commensal organism to nosocomial pathogen","volume":"4","author":"Willems","year":"2009","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20171014000644_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/14787210.6.5.637","article-title":"Emergence and management of drug-resistant enterococcal infections","volume":"6","author":"Arias","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20171014000644_bib16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1055\/s-2007-996410","article-title":"Optimizing therapy for vancomycin-resistant enterococci (VRE)","volume":"28","author":"Linden","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014000644_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/526775","article-title":"Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline","volume":"46","author":"Anthony","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014000644_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1078155206069165","article-title":"Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans","volume":"12","author":"Green","year":"2006","journal-title":"J Oncol Pharm Pract"},{"key":"key\n\t\t\t\t20171014000644_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/432121","article-title":"Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection","volume":"41","author":"Munoz-Price","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014000644_bib20"},{"key":"key\n\t\t\t\t20171014000644_bib21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmb.2009.06.064","article-title":"Vancomycin and oritavancin have different modes of action in Enterococcus faecium","volume":"392","author":"Patti","year":"2009","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20171014000644_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1574-6976.2003.tb00628.x","article-title":"Mechanism of action of oritavancin and related glycopeptide antibiotics","volume":"26","author":"Allen","year":"2003","journal-title":"FEMS Microbiol Rev"},{"key":"key\n\t\t\t\t20171014000644_bib23","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/AAC.00760-10","article-title":"Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing","volume":"54","author":"Belley","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib24","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1128\/AAC.01513-07","article-title":"Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing","volume":"52","author":"Arhin","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib25","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/AAC.40.10.2416","article-title":"In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci","volume":"40","author":"Schwalbe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.43.1.115","article-title":"Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis","volume":"43","author":"Saleh-Mghir","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib27","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.00197-09","article-title":"Impact of human serum albumin on oritavancin in vitro activity against enterococci","volume":"53","author":"McKay","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jac\/dkp126","article-title":"Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium","volume":"63","author":"McKay","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib29","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/AAC.44.11.3017-3021.2000","article-title":"Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis","volume":"44","author":"Lefort","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib30","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1128\/AAC.00271-10","article-title":"Assessment of oritavancin serum protein binding across species","volume":"54","author":"Arhin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib31","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1128\/AAC.00952-09","article-title":"Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates","volume":"53","author":"Arhin","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib32","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/AAC.00084-11","article-title":"Characterizing vancomycin-resistant Enterococcus (VRE) strains with varying daptomycin (DAP) resistance developed in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"55","author":"Steed","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014000644_bib33","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/AAC.43.8.1875","article-title":"Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci","volume":"43","author":"Arthur","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/54\/suppl_3\/S233\/20910792\/cir924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T12:54:46Z","timestamp":1593867286000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/54\/suppl_3\/S233\/290191\/Unmet-Needs-and-Prospects-for-Oritavancin-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":33,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2012,4,15]]},"published-print":{"date-parts":[[2012,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cir924","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,4,15]]},"published":{"date-parts":[[2012,4,15]]}}}